Heterogeneous secretion of individual B cells in response to D-glucose and to nonglucidic nutrient secretagogues.
We used a hemolytic plaque assay for insulin to determine whether the same pancreatic B cells respond to D-glucose, 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid (BCH) and the association of this nonmetabolized analogue of L-leucine with either the monomethyl ester of succinic acid (SME) or the dimethyl ester of L-glutamic acid (GME). During a 30-min incubation in the absence of D-glucose, BCH alone (5 mM) had no effect on insulin release. In contrast, the combination of BCH with either SME (10 mM) or GME (3 mM) stimulated insulin release to the same extent observed in the sole presence of 16.7 mM D-glucose. The effects of BCH plus SME and BCH plus GME on both percentage of secreting B cells and total insulin output were little affected in the presence of D-glucose concentrations ranging from 0 to 16.7 mM. Varying the concentration of SME from 2 to 10 mM also did not influence these effects. In other experiments, the very same B cells were first exposed 45 min to 16.7 mM D-glucose, then incubated 45 min in the presence of only BCH and SME. Under these conditions, most (80.3 +/- 2.5%) of the cells contributing to insulin release did so during both incubation periods. Furthermore, virtually all cells responding to BCH and SME during the second incubation corresponded to cells also responsive to D-glucose during the first incubation. Similar observations were made when the sequence of the two incubations was reversed.(ABSTRACT TRUNCATED AT 250 WORDS)
Bosco
D
D
Department of Morphology, University of Geneva, Switzerland.
Meda
P
P
Thorens
B
B
Malaisse
W J
WJ
D000596:Amino Acids / Q000494:pharmacology*; D000598:Amino Acids, Cyclic; D000818:Animals; D004268:DNA-Binding Proteins / Q000235:genetics*; D051766:Early Growth Response Protein 1; D005941:Glucokinase / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology*; D051273:Glucose Transporter Type 2; D005971:Glutamates / Q000494:pharmacology*; D006462:Hemolytic Plaque Technique; D017874:Immediate-Early Proteins; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007930:Leucine / Q000031:analogs & derivatives; D008297:Male; D009004:Monosaccharide Transport Proteins / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013386:Succinates / Q000494:pharmacology*; D014157:Transcription Factors / Q000235:genetics*
D000596:Amino Acids; D000598:Amino Acids, Cyclic; D004268:DNA-Binding Proteins; D051766:Early Growth Response Protein 1; C486110:Egr1 protein, rat; D051273:Glucose Transporter Type 2; D005971:Glutamates; D017874:Immediate-Early Proteins; D007328:Insulin; D009004:Monosaccharide Transport Proteins; D013386:Succinates; D014157:Transcription Factors; C006504:2-aminobicyclo(2,2,1)heptane-2-carboxylic acid; C035873:glutamic acid dimethyl ester; D005941:Glucokinase; D007930:Leucine; D005947:Glucose; C041105:monomethyl succinate